Global Summit on Improving the Bioavailability of Medicines 2022: two-day online program
Dublin, March 08, 2022 (GLOBE NEWSWIRE) — The “Global Summit on Improving Drug Bioavailability 2022” conference has been added to from ResearchAndMarkets.com offer.
Are you responsible for improving drug performance, bioavailability and patient adherence? Would you like to discover new strategies to reduce dosage, costs and reduce time to market of products?
Check out the 2022 Global Summit on Improving Drug Bioavailability program agenda and walk away with 2+ years of novel drug formulation and bioavailability improvement strategies. Learn directly from over 30 senior drug bioavailability pioneers and network with over 120 senior drug development innovators next May in Philadelphia, Pennsylvania.
The 2022 2-day program features the latest in industry formulation and delivery technologies to improve solubility and maximize bioavailability. The 2022 Summit will share cutting-edge research on the development, characterization and manufacturing of formulations spanning multiple modalities.
Precision Medicine and Healthcare Delivery
Rational formulation design for poorly soluble compounds
In-vivo – in-vitro correlation
Solution behavior of amorphous solid dispersions
Nanosuspension to improve bioavailability
Early Formulation Screening in Drug Discovery
3D printing for biopharma
Improving patient adherence via drug administration
Innovative strategies around drug/device combinations
2021 speakers included:
Manish Gupta, PhD
Senior Director, Pharmaceutical Development – Sterile
Dedong Wu, PhD
Senior Scientist, Solid State
Arijit Chakravarty, PhD
Chief Executive Officer
Rick Panicucci, PhD
Senior Vice President, CMC
Saji Vijayan, PhD
Vice President – R&D Strategy
Sune Anderson, Ph.D.
Senior Scientist, Spray Drying
Johnson & Johnson
Stephen Tindal, PhD
Director, Science and Technology
Catalent Pharmaceutical Solutions
Melanie Marota, PhD
Associate Principal Investigator, Pharmaceutical Sciences
Merck & Co.
Eric Munson, PhD
Patrick DeLuca Endowed Professor of Pharmaceutical Technology, Department of Pharmaceutical Sciences
Di Wu, PhD
Senior Scientist, Formulation Development
Merck & Co.
Stephen Stern, PhD
Director of Research and Development, Head of the Pharmacology and Toxicology Section
Nanotechnology Characterization Laboratory
Dabing Chen, Ph.D.
Senior Principal Scientist
Xin Liu, Ph.D.
Associate Director of Pharmaceutical Product Development
Sudhakar Garad, PhD
Global Head of Chemical and Pharmaceutical Profiling
For more information about this conference, visit https://www.researchandmarkets.com/r/nkj0rv
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900